Category: Oncology/Hematology
Global Oncology/Hematology
-
2024 Global: Cancer Supportive Care Drugs - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Cancer Immunotherapy - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
Oligonucleotide Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Antisense, Ribozymes, Aptamers, Mirna, Cpg/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Oligonucleotide Therapeutics market size is poised to register 9.41% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Oligonucleotide Therapeutics ... Read More
-
Cell and Gene Therapy Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Gene Therapy), By Gene Type, Gene silencing, Cell replacement, Gene augmentation, Others), By Cell Type (T-Cells, Stem Cells, Other), By Application (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy market size is poised to register 20.38% growth (CAGR) from 2024 to 2030, presenting significant growth ... Read More
-
Gastrointestinal Stent Market Assessment, By Product [Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, Esophageal Stents], By Material [Self–Expanding Metal Stents, Plastic Stents], By Application [Biliary Diseases, Irritable Bowel Syndrome, Gastrointestinal Cancers, Colorectal Cancer, Stomach Cancer, Esophageal Cancer, Pancreatic Cancer], By End-user [Hospitals and Clinics, Ambulatory Surgical Centers], By Region, Opportunities and Forecast, 2017-2031F
... Cancer, Esophageal Cancer, Pancreatic Cancer], By End-user [Hospitals and Clinics, Ambulatory Surgical Centers], By Region, Opportunities and Forecast, 2017-2031F Global gastrointestinal stent market is projected to witness a CAGR of 5.35% during the forecast period ... Read More
-
Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering) Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology) End User - Global Forecast to 2031
... Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering) Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology) End User—Global Forecast to 2031 The global regenerative medicine market is projected to reach $37.27 ... Read More
-
Technology Landscape, Trends and Opportunities in the Global Cancer Biomarker Market
... biomarker. The rising wave of new technologies such as omics and bioinformatics are creating significant potential for advanced cancer biomarker in various medical platforms due to its feature of carefully addressing the heterogeneity issues. In ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Global Cancer Vaccines Drug Pipeline Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Cancer Vaccines Drug Pipeline is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Cancer Stem Cells Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Cancer Stem Cells is forecast to a readjusted size of US$ 1912.8 million by 2030 with a CAGR of 12.5% during review period. The research report highlights the growth potential ... Read More
-
Tumor Profiling Market Size, Trends, Analysis, and Outlook By Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Others), By Biomarker, Genomic Biomarker, Protein Biomarker), By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), by Region, Country, Segment, and Companies, 2024-2030
... Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), by Region, Country, Segment, and Companies, 2024-2030 The ... Read More
-
Cancer Biological Therapy Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Cancer growth Blockers, Monoclonal Antibodies, Blood Cell Growth Factors, Gene Therapy), By Cancer (Pancreatic Cancer, Lung Cancer, Blood Cancer, Colorectal Cancer, Others), By Distribution Channel (Specialized cancer treatment centers, Hospitals Pharmacies, Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Specialized cancer treatment centers, Hospitals Pharmacies, Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Cancer Biological Therapy market size is poised to register 7.88% growth from 2024 to 2030, presenting ... Read More
-
Cell and Gene Therapy Bioanalytical Testing Services Market Size, Trends, Analysis, and Outlook By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Others), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage Of Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy Bioanalytical Testing Services market size is poised to register ... Read More
-
Cancer Gene Therapy Market Size, Trends, Analysis, and Outlook By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), By End-User (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Cancer Gene Therapy market size is poised to register 20.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Gene Therapy ... Read More
-
Global Head and Neck Cancer Drugs & Therapeutics Market Growth (Status and Outlook) 2024-2030
... at US$ million in 2023. With growing demand in downstream market, the Head and Neck Cancer Drugs & Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Leukemia Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Screening Software
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for NDDS in Cancer Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Checkpoint Inhibitors for Anti-Cancer Treatments
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
Research Assistance
